U.S. Home Infusion Therapy Market Size

U.S. Home Infusion Therapy Market Size

U.S. Home Infusion Therapy Market size was valued at USD 12.4 billion in 2023 and is expected to exhibit growth at a CAGR of 10.1% from 2024 to 2032. High market growth can be attributed to the ongoing advancements in medical technology, rising prevalence of chronic diseases, growing hospital acquired infections, and rising geriatric population, among other contributing factors.

To get key market trends

  Download Free Sample

Home infusion therapy refers to the administration of medications and biologicals intravenously or via other non-oral routes, such as subcutaneously, in a patient’s home. This therapy is designed to treat a wide range of medical conditions, including infections, dehydration, gastrointestinal diseases, and chronic diseases that require long-term drug administration.
 

The aging demographic in the U.S. increases the prevalence of chronic diseases and conditions that require ongoing medical treatment. Elderly patients often prefer home-based care to institutional settings, contributing to the demand for home infusion therapy. For instance, according to the data published by Population Reference Bureau (PRB), the number of Americans aged 65 and older is expected to climb from 58 million in 2022 to 82 million by 2050. Thus, growth in the elderly population fuels demand for home healthcare services, including infusion therapy, as part of comprehensive disease management strategies.
 

Furthermore, integration of infusion devices with digital health platforms and telehealth solutions enhances remote monitoring and management of patients receiving home infusion therapy. Connectivity enables real-time data transmission, remote patient monitoring, and proactive healthcare interventions. Improved patient outcomes, reduced hospital readmissions, and operational efficiencies drive adoption of technologically integrated home infusion solutions.